People · Operator

Mark Brooke Montondon

Named in public records as an officer, director or promoter · active 2009–2010 · Other Health Care, Hospitals and Physicians

4
Companies
5
Filings
$5.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
SL Pathology Leasing of Texas, LLCOther Health CareSeed$2.6M$4.0M2009
SL Seattle IMRT, LLCHospitals and PhysiciansPre-Seed$1.3M$24.4M2010
SL Santa Monica IMRT, LLCHospitals and PhysiciansPre-Seed$1.0M$28.7M2009
SL West Houston IMRT, LLCHospitals and PhysiciansPre-Seed$469K$766K
Operator network

Mark Brooke Montondon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Carl Lee Britton · 1 companies · 1 sharedCarl Lee BrittonMark B. Montondon · 1 companies · 1 sharedMark B. MontondonT.J. Farnsworth · 5 companies · 2 sharedT.J. FarnsworthChris Bright · 5 companies · 1 sharedChris BrightJeffery Evans · 1 companies · 1 sharedJeffery EvansT Brooke Farnsworth · 6 companies · 4 sharedT Brooke Farnswor…Jo Brooke Pollack · 1 companies · 1 sharedJo Brooke PollackSL Pathology Leasing of Texas, LLC · $2.6M raisedSL Pathology Leasing …SL Seattle IMRT, LLC · $1.3M raisedSL Seattle IMRT, LLCSL Santa Monica IMRT, LLC · $1.0M raisedSL Santa Monica IMRT,…SL West Houston IMRT, LLC · $0.5M raisedSL West Houston IMRT,…Mark Brooke MontondonMM
Mark Brooke Montondon Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Mark Brooke Montondon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
T Brooke Farnsworth46
T.J. Farnsworth25
Chris Bright15
Jeffery Evans11
Carl Lee Britton11
Mark B. Montondon11
Jo Brooke Pollack11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.